Innovate Pharmaceuticals

Innovate Pharmaceuticals is a UK-based biotechnology company focused on developing novel liquid formulations of established drugs to improve their therapeutic profile and patient outcomes. The company's primary asset, Infinispirin (IP1867), is a proprietary liquid aspirin formulation that enhances solubility and bioavailability while significantly reducing the gastrointestinal side effects typically associated with aspirin. Innovate is particularly focused on the application of Infinispirin in oncology, where research has demonstrated its potential to cross the blood-brain barrier and sensitize glioblastoma cells to chemotherapy. Beyond oncology, the company is exploring the use of its technology in treating chronic inflammatory conditions and cardiovascular diseases.